v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Assets:    
Cash and cash equivalents $ 8,586 $ 8,196
Investments 2,407 3,259
Accounts receivable, net 36,469 35,227
Inventories 18,107 18,025
Other current assets 3,076 3,151
Total current assets 68,645 67,858
Long-term investments 28,934 23,019
Property and equipment, net 12,993 13,183
Operating lease right-of-use assets 15,944 17,252
Goodwill 91,272 91,272
Intangible assets, net 27,323 29,234
Separate accounts assets 3,311 3,250
Other assets 4,793 4,660
Total assets 253,215 249,728
Liabilities:    
Accounts payable 15,892 14,897
Pharmacy claims and discounts payable 24,166 22,874
Health care costs payable 15,064 12,049
Accrued expenses and other current liabilities 20,810 23,515
Other insurance liabilities 1,183 1,141
Current portion of operating lease liabilities 1,751 1,741
Short-term debt 2,119 200
Current portion of long-term debt 3,624 2,772
Total current liabilities 84,609 79,189
Long-term operating lease liabilities 14,899 16,034
Long-term debt 60,527 58,638
Deferred income taxes 3,806 4,311
Separate accounts liabilities 3,311 3,250
Other long-term insurance liabilities 4,902 5,459
Other long-term liabilities 5,431 6,211
Total liabilities 177,485 173,092
Commitments and contingencies (Note 18)
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and capital surplus 49,661 48,992
Treasury stock, at cost: 518 and 480 shares at December 31, 2024 and 2023 (36,818) (33,838)
Retained earnings 62,837 61,604
Accumulated other comprehensive loss (120) (297)
Total CVS Health shareholders’ equity 75,560 76,461
Noncontrolling interests 170 175
Total shareholders’ equity 75,730 76,636
Total liabilities and shareholders’ equity $ 253,215 $ 249,728